Atomatic adjustment of Basal insulin infusion rates in type 1 diabetes using run-to-run control and case-based reasoning
File(s)1-AID_2017_paper_10.pdf (516.14 KB)
Accepted version
Author(s)
Herrero Vinas, P
Pesl, Peter
Reddy, Monika
Oliver, NIck
Georgiou, Pantelis
Type
Conference Paper
Abstract
People with type 1 diabetes mellitus rely on a basal-bolus insulin
regimen to roughly emulate how a non-diabetic person’s body delivers insulin.
Adjusting such regime is a challenging process usually conducted by an expert
clinical. Despite several guidelines exist for such purpose, they are usually
impractical and fall short in achieving optimal glycemic outcomes. Therefore,
there is a need for more automated and efficient strategies to adjust such regime.
This paper presents, and in silico validates, a novel technique to automatically
adapt the basal insulin profile of a person with person with type 1 diabetes. The
presented technique, which is based on Run-to-Run control and Case-Based
Reasoning, overcomes some of the limitations of previously proposed
approaches and has been proved to be robust in front of realistic intra-day
variability. Over a period of 5 weeks on 10 virtual adult subjects, a significant
reduction on the percentage of time in hyperglycemia (<70mg/dl) (from 14.3±5.6
to 1.6±1.7, p< 0.01), without a significant increase on the percentage of time in
hypoglycemia (>180mg/dl) (from 10.2±5.9 to 1.6±1.7, p=0.1), was achieved.
regimen to roughly emulate how a non-diabetic person’s body delivers insulin.
Adjusting such regime is a challenging process usually conducted by an expert
clinical. Despite several guidelines exist for such purpose, they are usually
impractical and fall short in achieving optimal glycemic outcomes. Therefore,
there is a need for more automated and efficient strategies to adjust such regime.
This paper presents, and in silico validates, a novel technique to automatically
adapt the basal insulin profile of a person with person with type 1 diabetes. The
presented technique, which is based on Run-to-Run control and Case-Based
Reasoning, overcomes some of the limitations of previously proposed
approaches and has been proved to be robust in front of realistic intra-day
variability. Over a period of 5 weeks on 10 virtual adult subjects, a significant
reduction on the percentage of time in hyperglycemia (<70mg/dl) (from 14.3±5.6
to 1.6±1.7, p< 0.01), without a significant increase on the percentage of time in
hypoglycemia (>180mg/dl) (from 10.2±5.9 to 1.6±1.7, p=0.1), was achieved.
Date Issued
2017-06-24
Date Acceptance
2017-05-24
Citation
2nd Workshop on Artificial Intelligence for Diabetes (AID2017), 2017
Journal / Book Title
2nd Workshop on Artificial Intelligence for Diabetes (AID2017)
Copyright Statement
© 2017 The Author(s)
Sponsor
Engineering & Physical Science Research Council (EPSRC)
Engineering & Physical Science Research Council (EPSRC)
National Institute for Health Research
National Institute for Health Research
Commission of the European Communities
Grant Number
EP/M027007/1
EP/M027007/1
II-LA-0214-20008
II-LA-0214-20008
689810
Source
Artificial Intelligence in Medicine
Publication Status
Published
Start Date
2017-06-24
Coverage Spatial
Vienna, Austria